News
No staff COVID-19 diagnoses after plan at Chinese cancer center
April 2, 2020
A cancer center in China has so far managed to protect all patients and staff from COVID-19.
News
Maintaining cancer care in the face of COVID-19
April 1, 2020
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect vulnerable patients from COVID-19.
News
Blood test might detect multiple cancer types, study suggests
March 31, 2020
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based screening.
![1]()
News
FDA okays emergency use of convalescent plasma for seriously ill COVID-19 patients
March 28, 2020
“It’s crucial that data be captured for every patient so that we really understand what safety and effectiveness looks like on as close to a real-world level as we can, as quickly as we can,” said Peter J. Pitts, a former associate commissioner of the FDA.
News
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
March 23, 2020
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
![1]()
News
DOACs for treatment of cancer-associated venous thromboembolism
January 23, 2020
Recent studies suggest DOACs may be a viable option in the treatment of malignancy-associated VTE.
![1]()
News
New ASH guideline: VTE prophylaxis after major surgery
December 12, 2019
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.
![1]()
News
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
![1]()
News
Transfusion-related lung injury is on the rise in elderly patients
November 14, 2019
SAN ANTONIO – Researchers at the Food and Drug Administration examined trends in potentially life-threatening or fatal transfusion-related adverse events in patients aged 65 years and older.
![1]()
News
Dose-reduced NOACs may be safer than warfarin in some AFib patients
October 31, 2019
Are dose-reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?
